Summary Nanotherapeutics Inc (Nanotherapeutics) is a biopharmaceutical company that develops and manufactures biopharmaceutical products. The company offers preclinical and clinical development, formulation optimization, cGMP manufacturing of biopharmaceuticals and quality control testing. Its services include process development, formulation development, analytical service, regulatory, and project management services. Nanotherapeutics’ proprietary platform technologies can be used in the production of proteins, monoclonal antibodies and vaccines. The company caters to commercial and government customers. It operates through its offices in the US and Czech Republic. Nanotherapeutics is headquartered in Alachua, Florida, the US. Nanotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from... Research Beam Model: Research Beam Product ID: 1995301 250 USD New
Nanotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Nanotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : August   2017
  • Pages : 25
  • Publisher : GlobalData
 
 
 
Summary

Nanotherapeutics Inc (Nanotherapeutics) is a biopharmaceutical company that develops and manufactures biopharmaceutical products. The company offers preclinical and clinical development, formulation optimization, cGMP manufacturing of biopharmaceuticals and quality control testing. Its services include process development, formulation development, analytical service, regulatory, and project management services. Nanotherapeutics’ proprietary platform technologies can be used in the production of proteins, monoclonal antibodies and vaccines. The company caters to commercial and government customers. It operates through its offices in the US and Czech Republic. Nanotherapeutics is headquartered in Alachua, Florida, the US.

Nanotherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nanotherapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Nanotherapeutics Acquires Biodefense Business from XOMA 11
Nanotherapeutics to Acquire Vero Cell Technology from Baxter 12
Nanotherapeutics Acquires Cloretazine And Triapine Products 13
Venture Financing 14
Nanotherapeutics Secures USD28.5 Million in Venture Debt Financing 14
Partnerships 15
Takeda Pharma Enters into Agreement with Nanotherapeutics 15
Licensing Agreements 16
Trethera Enters into Licensing Agreement with Nanotherapeutics 16
Acquisition 17
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 17
Nanotherapeutics Inc - Key Competitors 18
Nanotherapeutics Inc - Key Employees 19
Nanotherapeutics Inc - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Strategy And Business Planning 21
May 02, 2017: Nanotherapeutics Bohumil and Praha Vaccines Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic 21
Corporate Communications 22
Jun 22, 2017: Robert J. Hennessey Appointed Chairman of the Board of Nanotherapeutics 22
Jun 20, 2017: Peter H. Khoury, Ph.D., MBA Appointed President and Chief Executive Officer of Nanotherapeutics 23
Dec 01, 2016: Nanotherapeutics appoints president and CEO 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanotherapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Nanotherapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanotherapeutics Acquires Biodefense Business from XOMA 11
Nanotherapeutics to Acquire Vero Cell Technology from Baxter 12
Nanotherapeutics Acquires Cloretazine And Triapine Products 13
Nanotherapeutics Secures USD28.5 Million in Venture Debt Financing 14
Takeda Pharma Enters into Agreement with Nanotherapeutics 15
Trethera Enters into Licensing Agreement with Nanotherapeutics 16
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 17
Nanotherapeutics Inc, Key Competitors 18
Nanotherapeutics Inc, Key Employees 19
List of Figures
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nanotherapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter